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Abstract
Objective: Osteoarthritis (OA) is a multi-factorial disease and genetic factor is one of the important etiologic risk
factors. Various genetic polymorphisms have been elucidated that they might be associated with OA. Recently,
several studies have shown an association between Growth Differentiation Factor 5(GDF5) polymorphism and knee
OA. However, the role of genetic predisposing factor in each ethnic group cannot be replicated to all, with
conflicting data in the literatures. Therefore, the aim of this study was to investigate the association between GDF5
polymorphism and knee OA in Thai population.
Materials and Methods: One hundred and ninety three patients aged 54-88 years who attended Ramathibodi
Hospital were enrolled. Ninety cases with knee OA according to American College of Rheumatology criteria and
one hundred and three cases in control group gave informed consent. Blood sample (5 ml) were collected for
identification of GDF5 (rs143383) single nucleotide polymorphism by PCR/RFLP according to a standard protocol.
This study protocol was approved by the Ethics Committee on human experimentation of Ramathibodi Hospital
Faculty of Medicine, Mahidol University. Odds ratios (OR) and 95% confidence intervals were calculated for the risk
of knee OA by genotype (TT, TC and CC) and allele (T/C) analyses.
Results: The baseline characteristics between two groups including job, smoking and activity were not different,
except age and BMI. The entire cases and controls were in Hardy-Weinberg equilibrium (p > 0.05). The OA knee group
(n = 90) had genotypic figure which has shown by TT 42.2% (n = 38), TC 45.6% (n = 41) and CC 12% (n = 11), whereas
the control group (n = 103) revealed TT 32% (n = 33), TC 45.6% (n = 47), and CC 22.3% (n = 23), respectively. Genotypic
TT increased risk of knee OA as compared to CC [OR = 2.41 (P = 0.04, 95%CI = 1.02-5.67)]. In the allele analysis, the T
allele was found to be significantly associated with knee OA [OR = 1.53 (P = 0.043, 95%CI = 1.01-2.30)].
Conclusion: These data suggested that GDF5 polymorphism has an association with knee OA in Thai ethnic. This
finding also supports the hypothesis that OA has an important genetic component in its etiology, and GDF5
protein might play important role in the pathophysiology of the disease.
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Introduction
It is widely believed that osteoarthritis develops from an
imbalance between anabolic and catabolic processes or
homeostasis of cartilage metabolism [1,2]. The etiology
of this disease is related to genetic association [3].
Recently, several studies have demonstrated the poly-
morphism in many genes which might be related to the
pathogenesis of osteoarthritis [4-14]. Growth Differentia-
tion Factor 5 or GDF5 gene regulates the expression of
the GDF5 protein which is closely related to BMP and
is a member of TGF-beta superfamily [15]. It has a role
in regulation of the chondrogenesis and the defect in
this gene might be correlated to the abnormal joint
development [15]. It has been reported in animal study
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that GDF5 knockout mice develops knee joint anomaly
[16]. Moreover, it has been shown that he polymorph-
ism in GDF5 gene is related with low expression of the
GDF5 protein in knee joint [17].
The large scale analysis has shown that the association
of this polymorphism (rs143383) in promoter area
might be a risk factor of the osteoarthritis [18]. In addi-
tion, studies of this genetic variant in China and Japan
have shown the association of T allele and knee OA
[19]. However, there is a report from Greece which had
an inconsistent result and found no an association [20].
The genetic susceptibility of the disease in different eth-
nic cannot be applied to others because each ethnic has
a different genetic background. There is a gap of infor-
mation about this polymorphism in Thai population,
therefore the objective of this study is to determine the
association of the SNP rs143383 in GDF5gene and knee
OA in Thai population.
Patients and Methods
Subjects
Our study was approved by the Ethics Committee of the
Faculty of Medicine, Ramathibodi Hospital, Mahidol
University, Bangkok, Thailand. All patients recruited in
the study were Thai by nationality and had ancestors
settled in Thailand for at least three generations. In
total, 90 patients with knee OA who underwent total
knee arthroplasty (TKA) and 103 patients without knee
OA were enrolled from Department of Orthopedics,
Ramathibodi Hospital. Informed consent was performed
after the purpose of the research project and it had
been clearly explained to the patients. The diagnosis of
knee OA was based on the American College of Rheu-
matology criteria [21]. Both OA and control groups
were interviewed to obtain demographic data and all of
established risk factors. Thereafter, standard weight-
bearing antero-posterior and lateral view of knee radio-
graphs were taken to confirm the diagnosis of OA by
Kellgren and Lawrence scores (KL scores) [22].
Laboratory technique
PCR-RFLP for BsiEI restriction site was used for SNP in GDF-
5 identification
Firstly, 5 ml peripheral blood sample was collected from
patient using ethylenediamine tetraacetic acid as an
anticoagulant and processed for SNP analysis. Genomic
DNA was extracted from buffy coat leukocytes using the
standard phenol-chloroform method. PCR primers to
amplify the promoter area of GDF5 gene were designed
by the Primer-3 web-based tool [23]: GATTTTTTCT-
GAGCACCTGCAGG (forward) and GTGTGTGTT
TGTATCCAG (reverse). 50 μl PCR mixture contained
100 ng of genomic DNA, 20 pmol of each primer, 0.2 μ
M of each dNTP, 1 unit of Taq DNA polymerase
(AmpliTaq®, Applied Biosystem, Foster City, CA), 3.0
mM MgCl2 in 10 × PCR buffer containing 10 mmol of
Tri-HCl pH 9.0, 10 mmol KCl and 0.1% Triton X-100
(Invitrogen, Carlsbad, CA). PCR reaction was started
with an initial denaturation at 95°C for 5 min, followed
by 35 cycles of amplification in a thermocycler (PCR
Sprint, Thermofisher, Waltham, MA) with denaturation
at 94°C for 1 min, annealing at 58°C for 1 min, exten-
sion at 72°C for 1 min, and final extension at 72°C for
10 min. Then, 10 μL of PCR product was incubated at
37°C with 3 units of BsiEI for 4 hours under the manu-
facturer’s recommended conditions (New England Bio-
labs, Ipswich, MA). The digested product was
electrophoresed on 2% agarose gel with ethidium bro-
mide staining before being visualized on a UV transillu-
minator (Figure 1). The expected fragment length was
104 and 230 bp in CC, 104, 230, and 344 bp in TC, and
344 bp in TT genotypes, respectively.
Statistical analyses
Analysis of demographic data was performed by Excel
2007 (Microsoft® Excel®). The unpaired t-test was used
for continuous data and Chi-square was used for catego-
rical data. Allele frequencies, Odds ratio and the prob-
ability for Hardy-Weinberg Equilibrium were estimated
and analyzed as explained by following website; http://
ihg.gsf.de/cgi-bin/hw/hwa1.pl.
Results
In our study, the average age of patients in the knee OA
group was significant older than in the control. BMI
which is one of the risk factor of knee OA was also
slightly higher in the OA patient group. However, other
Figure 1 shows the bands of each genotype in the
electrophoresis gel: A represents TT, B represents CC and C
represents TC.
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possible risk factors which might be related to OA as
well as patient life style were comparable between these
two groups. The baseline characteristics of the patients
are shown in Table 1. The prevalence of allele T and C
in our sample was normally distributed according to the
Hardy-Weinberg Equilibrium (p-value < 0.05). The com-
parison of the number and odd ratio of genotype TT,
TC, TT+TC with CC of GDF5 polymorphism
(rs143383) in the promoter area between case and con-
trol is demonstrated in Table 2. When analyzing by
allele (shown in table 3), the odds ratio of T allele was
1.53 (95%C.I. = 1.01-2.31), which delineated the increase
in risk to develop knee OA. Our result shown that this
polymorphism, T/C, is inherited by autosomal recessive
manner as the TT genotype increases risk of the disease
significantly (OR = 2.41, 95%C.I. = 1.02-5.67), whereas
the TC has no significant difference.
Discussion and Conclusion
Our study has shown the statistically significant associa-
tion between polymorphism in promoter of GDF5 gene
(rs143383) and knee osteoarthritis in Thai population.
We found that T allele in GDF5 polymorphism was a
significant risk factor for knee osteoarthritis with Odds
ratio 1.53 (95%C.I. = 1.01-2.31). When analysed by gen-
otype, it was found that the TT genotype increased risk
of knee OA, whereas TC has not shown any correlation.
Regarding these finding, it suggests that this poly-
morphic gene might be expressed as the autosomal
recessive type. The GDF5 gene is located on the chro-
mosome 20q11.2 and it regulates the expression of
GDF5 protein. It is categorised in the class of bone mor-
phogenetic protein (BMP) [15]. It involves in develop-
ment of bone and cartilage, particularly in endochondral
ossification process [24,25]. The mutation of GDF5
associates with generalised osteoarthritis and skeletal-
related congenital diseases. Acromesomelic chondrodys-
plasia; Grebe type and Hunter-Thompson type is
autosomal recessive form which is rare hereditary skele-
tal disorders. They are presented by short status, abnor-
mal limbs development. Brachydactyly type A1, A2 and
C and symphalangism proximal syndrome are inherited
malformation presented with abnormal morphology of
hand and finger. Multiple synostoses syndrome type 2 is
an autosomal dominant condition characterised by pro-
gressive joint fusions and progressive conductive deaf-
ness. Du Pan syndrome is a rare autosomal recessive;
the patient presents with absence of the fibulae and
severe acromesomelic limb shortening with small, non-
functional toes. These abnormal conditions have been
reported that they have a mutation in GDF5 gene, thus
they support that GDF5 plays a role in skeletal develop-
ment [26,27]. Recently, it has been reported that GDF5
deficiency mice had the delay fracture healing process
that impaired the cartilaginous matrix deposition in the
callus and reduced callus cross-sectional area [28].
The functional study of this polymorphism has been
demonstrated; T allele in rs143383 was associated with
the decrease of GFD5 molecule expression and might
increase susceptibility to osteoarthritis [17]. Moreover, it
has been report that the differential binding of deformed
epidermal autoregulatory factor 1 (DEAF-1) can modu-
late the expression of GDF5 via this polymorphism [29].
It is believed that GDF5 plays role in the regulation of
the chondrogenic cell growth and differentiation. These
evidences support the function of GDF5 gene which
might indicate the importance of this polymorphism in
osteoarthritis etiology. As the result, many scientists
have been working for study the association of this poly-
morphism in GDF5 gene. Recently, a large scale associa-
tion study between GDF5 gene and osteoarthritis has
revealed the genetic susceptibility of polymorphism in







Age (years), mean (SD) 68.46(10.0) 59.25(9.0) < 0.01*
Onset of disease (years), mean (SD) 61.46(9.06) N/A N/A
Female (%) 79(87.25) 93(90.29) 0.7
BMI (kg/m2), mean (SD) 26.66(4.0) 24.57(5.0) < 0.01*
History of labor work (%) 25(27.78) 30(29.13) 0.20
Regular exercise (%) 10(11.11) 13(12.62) 0.15
Kneeling activity (%) 37(41.11) 48(46.60) 0.07
Previous any fracture (%) 9(10.0) 13(12.62) 0.15
Smoking (%) 2(2.22) 4(3.88) 0.10
Note: *statistically significant, SD = standard deviation, N/A = not applicable
Table 2 Shows the association between each genotype








TT 38 33 2.41(1.022-5.670) 0.04*
TC 41 47 1.82(0.794-4.190) 0.15
TT + TC 79 80 2.07(0.944-4.517) 0.06
CC 11 23 1 N/A
(CC was used for calculation Odd ratio of TT, TC and TT+TC)
Notes: *statistically significant, N/A = not applicable
Table 3 Shows the association between allele and knee
OA
Allele Case Control Odds ratio (95%CI) p-value
T 117 113 1.53(1.013-2.306) 0.04*
C 63 93 1 N/A
(C was used for calculation Odd ratio of T)
Notes: *statistically significant, N/A = not applicable
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the GDF5; rs143383 with odds ratio 1.12 (95%CI 0.99-
1.31) [18]. This study included the data from diverse
ethnics which have been reported in the recent litera-
tures. However, the magnitude of this association is
smaller than the Asian ethnic, it has been reported from
Japan that odds ratio is 1.79 (P = 1.18 × 10-13) for
GDF5 polymorphism with per-risk allele (T) odds ratio
by Miyamoto et al [17]. The magnitude of the associa-
tion of GDF5 polymorphism is different between Cauca-
sian ethnic and Asian ethnic. Furthermore, the
association of this polymorphism from Greek and Kor-
ean study cannot demonstrate the association of GDF5
polymorphism [20,30]. We have also reported the poly-
morphism in ESR1, which is associated with knee OA in
Korean population. However, our result did not show
any statistically significant difference [31]. Thus, these
evidences can imply that the association of ethic and
genetic susceptibility in osteoarthritis might not be con-
sistent among the different populations and cannot be
applied to others.
In addition, there is a report that GDF5 polymorphism
(rs143383) also predisposes to Lumbar disc degeneration
in women. Lumbar disc degeneration which is defined
by disc space narrowing and the presence of osteophytes
significantly associates with GDF5 polymorphism from
cohorts from Northern Europe in women, with an odds
ratio (OR) of 1.72 (95% CI 1.15-2.57) [32]. The genome-
wide association study from Finland and Sardinia shows
the common variants in GDF5 contribute to height dif-
ference [33]. The GDF5 gene might be involved skeletal
growth and development and GDF5 variants might play
role in pathogenesis of bone and cartilage diseases.
Although the sample size in our study was small when
compared to previous studies, these limited samples
were sufficient for demonstrating the statistically signifi-
cant association of rs143383 in GDF5 core promotor
area. Furthermore, the population in our study was in
homogeneity and the distribution between the case and
control groups was in the Hardy Weinberg’s equili-
brium. Therefore, our study can represent the significant
susceptibility of GDF5 in knee osteoarthritis in Thai eth-
nic. Our findings have emphasized this association that
the susceptibility of the polymorphism in GDF5 among
the Asian population because the magnitude of associa-
tion is close to Japan and Chinese population. It is pos-
sible that Thai population ethnic is believed to be close
to Chinese ancestry. Finally, we decide to leave some
suggestions in genetic susceptibility study. Firstly, it is
important to study the genetic susceptibility in common
disease as this might be valuable for further investiga-
tion in order to understand the disease at molecular
level or even apply to use for disease screening. More
important, the association between polymorphism and
disease might not similar in different ethics; therefore
the genetic susceptibility from different ethics is
required and the meta-analysis should be conducted in
the adjacent area or similar genetic background. Lastly,
other modern technology such as microarray technique
should be employed for investigation of genetic suscept-
ibility in osteoarthritis.
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